Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Sell
10
IBBQ Quote, Financials, Valuation and Earnings
Last price:
$21.68
Seasonality move
:
-5.75%
Day range:
$21.62 - $21.90
52-week range:
$20.14 - $24.84
Dividend yield:
1.13%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
10.1K
Avg. volume:
12.6K
1-year change:
0.83%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
-- | -- | -- | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$21.75 | -- | -- | -- | $0.06 | 1.13% | -- |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
$51.83 | -- | -- | -- | $0.40 | 1.65% | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
$105.61 | -- | -- | -- | $0.09 | 0.41% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.15 | -- | -- | -- | $0.00 | 0% | -- |
|
IBB
iShares Biotechnology ETF
|
$133.52 | -- | -- | -- | $0.06 | 0.29% | -- |
|
IHI
iShares US Medical Devices ETF
|
$59.29 | -- | -- | -- | $0.11 | 0.46% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 1.252 | -- | -- |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
-- | 1.943 | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | 1.296 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.788 | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | 1.446 | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | 1.148 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
-- | -- | -- | -- | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Nasdaq Biotechnology ETF vs. Competitors
-
Which has Higher Returns IBBQ or BIB?
ProShares Ultra Nasdaq Biotechnology has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat ProShares Ultra Nasdaq Biotechnology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- BIBProShares Ultra Nasdaq Biotechnology-- -- -- -
What do Analysts Say About IBBQ or BIB?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Nasdaq Biotechnology has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than ProShares Ultra Nasdaq Biotechnology, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than ProShares Ultra Nasdaq Biotechnology.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 BIBProShares Ultra Nasdaq Biotechnology0 0 0 -
Is IBBQ or BIB More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ProShares Ultra Nasdaq Biotechnology has a beta of 1.340, suggesting its more volatile than the S&P 500 by 34.013%.
-
Which is a Better Dividend Stock IBBQ or BIB?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.13%. ProShares Ultra Nasdaq Biotechnology offers a yield of 1.65% to investors and pays a quarterly dividend of $0.40 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. ProShares Ultra Nasdaq Biotechnology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or BIB?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than ProShares Ultra Nasdaq Biotechnology quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than ProShares Ultra Nasdaq Biotechnology's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while ProShares Ultra Nasdaq Biotechnology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for ProShares Ultra Nasdaq Biotechnology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- BIBProShares Ultra Nasdaq Biotechnology-- -- -- --
-
Which has Higher Returns IBBQ or FXH?
First Trust Health Care AlphaDEX Fund has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat First Trust Health Care AlphaDEX Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- FXHFirst Trust Health Care AlphaDEX Fund-- -- -- -
What do Analysts Say About IBBQ or FXH?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Health Care AlphaDEX Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than First Trust Health Care AlphaDEX Fund, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than First Trust Health Care AlphaDEX Fund.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 FXHFirst Trust Health Care AlphaDEX Fund0 0 0 -
Is IBBQ or FXH More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust Health Care AlphaDEX Fund has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.906%.
-
Which is a Better Dividend Stock IBBQ or FXH?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.13%. First Trust Health Care AlphaDEX Fund offers a yield of 0.41% to investors and pays a quarterly dividend of $0.09 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. First Trust Health Care AlphaDEX Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or FXH?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than First Trust Health Care AlphaDEX Fund quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than First Trust Health Care AlphaDEX Fund's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while First Trust Health Care AlphaDEX Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for First Trust Health Care AlphaDEX Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- FXHFirst Trust Health Care AlphaDEX Fund-- -- -- --
-
Which has Higher Returns IBBQ or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About IBBQ or HTEC?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is IBBQ or HTEC More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, suggesting its more volatile than the S&P 500 by 6.985%.
-
Which is a Better Dividend Stock IBBQ or HTEC?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.13%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or HTEC?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns IBBQ or IBB?
iShares Biotechnology ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- IBBiShares Biotechnology ETF-- -- -- -
What do Analysts Say About IBBQ or IBB?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than iShares Biotechnology ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than iShares Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 IBBiShares Biotechnology ETF0 0 0 -
Is IBBQ or IBB More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.740, suggesting its less volatile than the S&P 500 by 26.046%.
-
Which is a Better Dividend Stock IBBQ or IBB?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.13%. iShares Biotechnology ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.06 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or IBB?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- IBBiShares Biotechnology ETF-- -- -- --
-
Which has Higher Returns IBBQ or IHI?
iShares US Medical Devices ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- IHIiShares US Medical Devices ETF-- -- -- -
What do Analysts Say About IBBQ or IHI?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than iShares US Medical Devices ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than iShares US Medical Devices ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 IHIiShares US Medical Devices ETF0 0 0 -
Is IBBQ or IHI More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 0.904, suggesting its less volatile than the S&P 500 by 9.601%.
-
Which is a Better Dividend Stock IBBQ or IHI?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.13%. iShares US Medical Devices ETF offers a yield of 0.46% to investors and pays a quarterly dividend of $0.11 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or IHI?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- IHIiShares US Medical Devices ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
